Intelligent Bio Solutions starts interference study for FDA drug screening submission
Go back to Intelligent Bio Solutions starts interference study for FDA drug screening submission| (NASDAQ: INBS) | Delayed: 2.51 -0.14 (5.28%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.65 | 52 Week High | $ | |||
| Open | $2.66 | 52 Week Low | $ | |||
| Day High | $2.70 | P/E | N/A | |||
| Day Low | $2.42 | EPS | $ | |||
| Volume | 48,648 | |||||

